MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

Search

Elanco Animal Health Inc

Chiusa

SettoreSettore sanitario

9.16 -5.57

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

8.98

Massimo

9.18

Metriche Chiave

By Trading Economics

Entrata

-372M

-8M

Vendite

-10M

1B

P/E

Media del settore

15.441

63.778

EPS

0.14

Margine di Profitto

-0.784

Dipendenti

9,000

EBITDA

-779M

8M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+57.72% upside

Dividendi

By Dow Jones

Utili prossimi

7 mag 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-279M

5.2B

Apertura precedente

14.73

Chiusura precedente

9.16

Notizie sul Sentiment di mercato

By Acuity

19%

81%

29 / 386 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Elanco Animal Health Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

27 giu 2024, 14:34 UTC

I principali Market Mover

Elanco Shares Retreat Over Zenrelia Warning Label Concerns

9 lug 2024, 12:30 UTC

Acquisizioni, Fusioni, Takeovers

Merck Animal Health Completes Acquisition Of Elanco's Aqua Business >MRK

9 lug 2024, 12:29 UTC

Acquisizioni, Fusioni, Takeovers

Elanco Animal Health Sees Ending 2024 With Net Debt to Adjusted Ebitda in Mid-4x Range >ELAN

9 lug 2024, 12:28 UTC

Acquisizioni, Fusioni, Takeovers

Elanco Animal Health: $1.05B-$1.1B Net Proceeds Available for Debt Paydown in 3Q >ELAN

9 lug 2024, 12:28 UTC

Acquisizioni, Fusioni, Takeovers

Elanco Completes Sale of Aqua Business to Merck >ELAN MRK

2 mag 2024, 17:43 UTC

Utili

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 mag 2024, 13:06 UTC

Utili

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

Confronto tra pari

Modifica del prezzo

Elanco Animal Health Inc Previsione

Obiettivo di Prezzo

By TipRanks

57.72% in crescita

Previsioni per 12 mesi

Media 15.33 USD  57.72%

Alto 20 USD

Basso 12 USD

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Elanco Animal Health Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

10 ratings

7

Acquista

3

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

N/A / 10.53Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Weak Bearish Evidence

A lungo termine

Weak Bearish Evidence

Sentiment

By Acuity

29 / 386 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.